Have your own idea? Try our Stock Screener
Brazilian (BOVESPA) Healthcare Sector Analysis
UpdatedSep 27, 2025
DataAggregated Company Financials
Companies16
- 7D-2.2%
- 3M9.9%
- 1Y3.3%
- YTD41.2%
Over the last 7 days, the Healthcare industry has dropped 2.2%, driven by Rede D'Or São Luiz declining 2.3%. On the other hand Biomm is actually up 16%. In the past year, the industry has gained 3.3%. As for the next few years, earnings are expected to grow by 27% per annum.
Sector Valuation and Performance
Has the Brazilian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 27 Sep 2025 | R$152.8b | R$149.9b | R$2.5b | 11.9x | 61.2x | 1x |
| Mon, 25 Aug 2025 | R$144.3b | R$144.3b | R$2.5b | 12.1x | 57.9x | 1x |
| Wed, 23 Jul 2025 | R$131.4b | R$149.5b | R$2.0b | 11.1x | 64.5x | 0.9x |
| Fri, 20 Jun 2025 | R$142.3b | R$149.5b | R$2.0b | 11.3x | 69.8x | 1x |
| Sun, 18 May 2025 | R$143.2b | R$149.6b | R$2.0b | 10.9x | 70x | 1x |
| Tue, 15 Apr 2025 | R$121.4b | R$150.7b | R$2.2b | 10.5x | 55.2x | 0.8x |
| Thu, 13 Mar 2025 | R$113.1b | R$148.1b | R$4.9b | 10.9x | 23x | 0.8x |
| Sat, 08 Feb 2025 | R$117.2b | R$146.7b | R$4.7b | 11.4x | 25.1x | 0.8x |
| Mon, 06 Jan 2025 | R$107.7b | R$146.7b | R$4.7b | 10.6x | 23.1x | 0.7x |
| Wed, 04 Dec 2024 | R$119.7b | R$146.7b | R$4.7b | 12x | 25.7x | 0.8x |
| Fri, 01 Nov 2024 | R$139.0b | R$144.9b | R$4.4b | 11.4x | 31.6x | 1x |
| Sun, 29 Sep 2024 | R$148.1b | R$144.9b | R$4.4b | 11.5x | 33.6x | 1x |
| Tue, 27 Aug 2024 | R$160.6b | R$144.9b | R$4.4b | 11.8x | 36.5x | 1.1x |
| Thu, 25 Jul 2024 | R$140.0b | R$143.3b | R$4.2b | 11.3x | 33.6x | 1x |
| Sat, 22 Jun 2024 | R$134.2b | R$142.9b | R$4.2b | 11.5x | 32.1x | 0.9x |
| Mon, 20 May 2024 | R$154.4b | R$142.9b | R$4.2b | 12x | 37x | 1.1x |
| Wed, 17 Apr 2024 | R$132.6b | R$140.0b | R$3.2b | 11.6x | 41.8x | 0.9x |
| Fri, 15 Mar 2024 | R$145.9b | R$133.3b | R$2.6b | 14.4x | 55.3x | 1.1x |
| Sun, 11 Feb 2024 | R$148.3b | R$132.9b | R$2.7b | 17x | 54.7x | 1.1x |
| Tue, 09 Jan 2024 | R$164.7b | R$135.0b | R$2.9b | 20.4x | 57.1x | 1.2x |
| Thu, 07 Dec 2023 | R$162.3b | R$135.0b | R$2.9b | 20.2x | 56.3x | 1.2x |
| Sat, 04 Nov 2023 | R$151.1b | R$126.2b | R$2.8b | 18x | 54.4x | 1.2x |
| Mon, 02 Oct 2023 | R$163.7b | R$126.1b | R$2.7b | 19.1x | 59.6x | 1.3x |
| Wed, 30 Aug 2023 | R$174.6b | R$126.1b | R$2.7b | 20.6x | 63.5x | 1.4x |
| Fri, 28 Jul 2023 | R$197.0b | R$116.7b | R$2.8b | 16.5x | 69.9x | 1.7x |
| Sun, 25 Jun 2023 | R$183.3b | R$116.7b | R$2.8b | 16.3x | 65x | 1.6x |
| Tue, 23 May 2023 | R$161.2b | R$110.8b | R$2.8b | 14.9x | 58.5x | 1.5x |
| Thu, 20 Apr 2023 | R$128.4b | R$106.3b | R$3.3b | 14.2x | 38.6x | 1.2x |
| Sat, 18 Mar 2023 | R$133.0b | R$104.5b | R$3.7b | 14.2x | 35.8x | 1.3x |
| Mon, 13 Feb 2023 | R$169.4b | R$98.3b | R$4.2b | 15.1x | 40.6x | 1.7x |
| Wed, 11 Jan 2023 | R$162.7b | R$98.3b | R$4.2b | 15.2x | 39x | 1.7x |
| Fri, 09 Dec 2022 | R$159.9b | R$98.3b | R$4.2b | 14.8x | 38.4x | 1.6x |
| Sun, 06 Nov 2022 | R$205.4b | R$90.9b | R$4.6b | 17.3x | 44.6x | 2.3x |
| Tue, 04 Oct 2022 | R$200.0b | R$90.4b | R$4.6b | 17x | 43.5x | 2.2x |
Price to Earnings Ratio
43.5x
Current Industry PE
- Investors are optimistic on the Brazilian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 61.2x which is higher than its 3-year average PE of 46.4x.
- The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 1.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 18% per year over the last three years.
- Meanwhile revenues for these companies have grown 18% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Brazilian Healthcare sector?
| BR Market | -0.56% | |
| Healthcare | -2.18% | |
| Medical Equipment | 5.82% | |
| Biotech | 2.02% | |
| Healthcare Services | -2.13% | |
| Pharma | -3.60% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry, which is trading close to its 3-year average PE ratio of 101x.
- Analysts are expecting annual earnings growth of 26.3%, which is higher than its past year's earnings growth of 18.9% per year.
- Investors are most pessimistic about the Medical Equipment industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 1.0x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 32% over the next 5 years.
- However this is lower than its past earnings growth rate of 44% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 6.4% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOM3 Biomm | R$9.98 | 15.8% +R$172.7m | -0.2% | PS9.1x | |
| FLRY3 Fleury | R$16.09 | 0.8% +R$65.4m | 3.2% | PE14.5x | |
| QUAL3 Qualicorp Consultoria e Corretora de Seguros | R$2.52 | 9.1% +R$59.1m | 9.1% | PE82.5x | |
| VVEO3 CM Hospitalar S/A | R$1.29 | 12.2% +R$44.2m | -31.0% | PS0.04x | |
| PFRM3 Profarma Distribuidora de Produtos Farmacêuticos | R$7.72 | 3.9% +R$35.6m | 39.1% | PE8x |
